Jahan Khamsehzadeh, Ph.D. joins us to explore the role both psilocybin specifically and fungi in general play in the evolution of life and consciousness.
Sara Ness joins us on Adventures Through The Mind to have a conversation about the art of conversation and its role in our relationships and vice versa. We also explore how play can help us develop and exercise our relational and conversational skills, specifically what are called Authentic Relating games.
Our guest for this episode of Adventures Through The Mind is Bob Falconer, whose work explores the intersection between IFS and psychedelics.
For this session of The Psychedelic Café we explore the question: Why Does Our Sense Of Connection Matter?
A.J. Bond—author of Discomfortable: What Is Shame and How Can We Break Its Hold?—joins us on Adventures Through The Mind to talk about what shame is, what it feels like, and how it impacts our sense of self and perception of the world.
Martijn Schirp of Synthesis Institute joins us on Adventures Through The Mind to wonder with us about the potential harms that will come from the profit-driven industrialization of psychedelics and psychedelic therapy; how we might safeguard the sacredness of psychedelics and people seeking psychedelic therapy against those harms.
Check Out The ATTMind Clips Youtube Playlist for short clips of various episodes
5-MeO-DMT and breath work facilitator Chad Charles joins me to discuss Leo Gura’s Outrageous Experiments In Consciousness–30 breakthrough 5-MeO-DMT trips in 30 days, at increasing doses, in isolation.
Dr. Oliver Grundmann joins us on Adventures Through The Mind to talk about Kratom. We discuss its traditional cultural use, legal history, pharmacology, modern cultural use, preparation best practices, its benefits and its risks, and how to safely start using kratom.
Dr. Frank Anderson joins us on Adventures Through The Mind to explore the Internal Family Systems model of therapy and its perspective on the nature of mind, trauma, “triggers”, and the symptoms of mental illness.
Francoise joins us on Adventures Through The Mind to discuss the Mazatec mushroom tradition and her decade-long journey bridging ingenious wisdom with the western traction while appreciating under traditional mushrooms curanderas.
Patrick Kroupa and I share an off-the-cuff conversation about COVID-19 and the pandemic’s impact on our personal and collective lives.
The Dank Duchess is on the show to discuss hashish, from what it means and how its made to why it matters in the modern cannabis market. We also discuss the ongoing impact of cannabis prohibition on black culture in the united states; harmful trends in the modern cannabis culture; and the power of hashish (and cannabis in general) to bridge our social divides and lay foundations for a better world.
Dr. Sam Gandy is on the show to explore the observation that psychedelics increase nature-relatedness and what that means for the climate crisis.
Mel Cassidy joins us on Adventures Through The Mind to explore how their models of understanding and engaging human relationships apply to understandings and engaging our relationship to psychedelics, psychedelic healing, and psychedelic communities.
David Grillot and Jonathan Glazer are the founders of #ThankYouPlantMedicine, a global wave of gratitude for psychedelics happening on February 20, 2020.
Chad joins us to talk about the problems present in the worldwide culture of 5-MeO-DMT and where the establishment of a Standard Of Care amongst facilitators might help address those problems.
Dr. Rosalind Watts joins us on the show to help breakdown and better understand the nuances of the psilocybin for depression trials she leads at Imperial College London, and the new trials she is currently leading.
David Krantz and I talk about how our unique genetics influence our metabolism of cannabis (nutrigenomics) and the resulting impact of cannabis use on our epigenetic health. Furthermore, we reach into a discussion on how the same framework of understanding applies to our metabolism of psychedelics and the potential future of a genome-specific screening program for psychedelic-assisted psychotherapy.
